Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial

BACKGROUND: Urinary tract infections (UTI) are among the most prevalent microbial diseases and their financial burden on society is substantial. The continuing increase of antibiotic resistance worldwide is alarming. Thus, well-tolerated, highly effective therapeutic alternatives are urgently needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Leitner, Lorenz, Sybesma, Wilbert, Chanishvili, Nina, Goderdzishvili, Marina, Chkhotua, Archil, Ujmajuridze, Aleksandre, Schneider, Marc P., Sartori, Andrea, Mehnert, Ulrich, Bachmann, Lucas M., Kessler, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615798/
https://www.ncbi.nlm.nih.gov/pubmed/28950849
http://dx.doi.org/10.1186/s12894-017-0283-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615798/
https://www.ncbi.nlm.nih.gov/pubmed/28950849
http://dx.doi.org/10.1186/s12894-017-0283-6

Ejemplares similares